ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Lloyd Conover, 93, died on March 11 in St. Petersburg, Fla.
“In 1952, Lloyd invented the broad-spectrum antibiotic tetracycline. This discovery grew from a scientific hunch: Working with a team that had determined the chemical structures of two Pfizer antibiotics, Aureomycin and Terramycin, Lloyd intuited that since the recently deduced chemical structures of these two antibiotics were identical but for one branch of each molecule—an extra chlorine atom in Aureomycin and an additional hydroxyl group in Terramycin—these anomalous branches might be superfluous. He reasoned that if one could remove them, the resulting compound might also be therapeutically active, perhaps more so than the parent drug. Undeterred by skepticism from his colleagues as to the likelihood of success, Lloyd and a lab assistant succeeded on the first try, using an untested technique. I remember Dad coming home with a calm smile that night and happily pronouncing one word: ‘Eureka!’ ”—Kirk Conover, son
Most recent title: senior vice president of agricultural research, Pfizer
Education: B.A., chemistry, Amherst College, 1947; Ph.D., chemistry, University of Rochester, 1950
Survivors: wife, Katharine; daughter, Heather; stepdaughters, Sue Love, Virginia Karpovich, Katharine Meacham, and Laura Keane; sons, Kirk, Roger, and Craig; stepsons, Walter Solomons and Andrew Meacham; 16 grandchildren; eight great-grandchildren
To recognize your late loved one or colleague, submit obituary information at cenm.ag/obits.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X